The effects of gestational age (GA), body weight, and prenatal exposure to betamethasone and indomethacin on the glomemlar filtration rate (GFR) on d 3 of life in preterm infants were studied. GFR measurements were performed in 147 preterm infants with a GA between 23.4 and 37.0 wk by means of the continuous inulin infusion technique. Mean GFR values increased significantly with GA (r = 0 . 6 0 ,~ < 0.001) and with body weight (r = 0 . 4 
,~ < 0.001).
Multivariate analysis indicated that GA was the most important determinant for this increase. Prenatal exposure to indomethacin resulted in significantly lower GFRvalues (-0.15 & 0.03 mUmin,p < 0.001) at d 3 after birth. Prenatal administration of betamethasone and indomethacin significantly (p < 0.001) increased the GFR in comparison with exposure to indomethacin alone to levels not different than those seen in patients who were not prenatally exposed to betamethasone or indomethacin. GFR measurements were repeated in 40 preterm infants on d 10 after birth. During this 7-d period, a significant increase in GFR values (0.17 ? 0.03 mUmin,p < 0.001) was detected. This postnatal increase in GFR values was independent of GA and was not influenced by prenatal exposure to betamethasone or indomethacin. We conclude that prenatal exposure to betamethasone or indomethacin exerts significant effects on the renal function of pretenn infants in the first days of life. (Pediatr Res 36: 578481,1994) Abbreviations GA, gestational age GFR, glomerular filtration rate RDS, respiratory distress syndrome Developmental changes in the GFR of preterm neonates have been the subject of many studies (1-7). Most reports indicated the presence of a GA-dependent increase in the GFR (1-6). In contrast, Aperia et al. (7) could not confirm these findings. Most studies included only a limited number of infants with a wide variation in postnatal age, and several different techniques were used to measure the GFR. Previous reports did not consider the possible effect of prenatal exposure to different drugs on these developmental changes of the GFR.
Betamethasone and indomethacin are potent drugs that are frequently used during pregnancy. Betamethasone is a synthetic glucocorticoid with a potency equivalent to dexamethasone. The drug is prescribed to pregnant women with an increased risk of preterm delivery before the 32nd wk of gestation. The objective of this treatment is to accelerate maturation of the alveolar epithelium and stimulate synthesis of lipid and protein components of the pulmonary surfactant complex to prevent hyaline membrane disease. We hypothesized that prenatal exposure to betamethasone might accelerate the maturation of the GFR. Indomethacin is prescribed to inhibit preterm uterine contractions before the 32nd wk of gestation. Short-term exposure to indomethacin leads to a reduction of the GFR, whereas conflicting data exist about the effect on the GFR after long-term exposure (8) (9) (10) . We therefore studied the effects of GA, birth weight, and prenatal exposure to betamethasone and indomethacin on the GFR in a large population of preterm infants on d 3 and 10 of life.
METHODS

Patients.
One hundred forty-seven preterm infants admitted to the neonatal intensive care unit of the Sophia Children's Hospital between October 1989 and October 1991 were included in this study. Eighty-seven infants were male and 60 were female. Infants who were born in our hospital at less than 37 wk of gestation were eligible for inclusion. The infants were hemodynamically stable (diuresis > 1 mL/kg/h; systolic and diastolic blood pressure above the third percentile adjusted for GA), had normal liver function, had not received inotropic or nephrotoxic drugs, did not have an intracranial hemorrhage beyond grade 11, and had an indwelling arterial catheter. The Po, in arterial blood was kept at greater than 50 mm Hg or oxygen saturation greater than 92%, and hematocrit values were maintained above 0.35 by packed erythrocyte transfusions. Infants were excluded from the study if they had life-threatening illnesses or became hemodynamically unstable (systolic and diastolic blood pressure below the third percentile adjusted for GA; diuresis < 1 mL/kg/h). The study protocol was approved by the Medical Ethical Committee of the University Hospital Rotterdam. Patients were only enrolled after informed consent was obtained from the parents.
The GA of the 147 children was estimated from the mother's menstrual history, early ultrasound examinations if available, and physical examination using the criteria of Dubowitz et al. (11) . Ninety-four children were not prenatally exposed to betamethasone or indomethacin (group A). Twenty-six children were prenatally exposed to indomethacin but not to betamethasone (group B). Only six children were prenatally exposed to betamethasone, but not to indomethacin (group C). Twenty-one children were prenatally exposed to both betamethasone and indomethacin (group D). Betamethasone had been administered in two i.v. doses of 12 mg each on 2 consecutive days. This dose was repeated every week until delivery or until the 32nd wk of gestation. Indomethacin had been administered in suppositories of 100 mg each, which were repeatedly given in the presence of preterm uterine contractions. In 40 infants, GFR measurements were repeated at d 10 after birth. Eighteen children were not prenatally exposed to betamethasone or indomethacin (group A). Thirteen children were prenatally exposed to indomethacin but not to betamethasone (group B). Two children were prenatally exposed to betamethasone, but not to indomethacin (group C). Seven children were prenatally exposed to both betamethasone and indomethacin (group D).
Laboratory studies. GFR values were determined by means of the continuous inulin infusion technique on the third day of life (5, 6, 12) . Inulin was obtained from Laevosan Gesellschaft mbH (Lienz, Austria) and was administered as a solution containing 25 g inulin/L at an infusion rate of 0.6 mL/kg/h. After 24 h, the inulin clearance (CL,) was calculated from the infusion rate (R), the inulin concentration in the infusate (I), and the serum inulin concentration (Pin) with the following equation: CL,, = I.R/Pin. The determination of inulin in serum was performed after acid hydrolysis in 0.3 mmol/L perchloric acid for 15 min at 70°C. The fructose thus formed was measured enzymatically according to Beutler (13) .
Statistical analysis. Data given are mean k SEM unless indicated otherwise. Correlation coefficients given are Pearson's. Comparison of groups was done using the t test. Multiple regression was used to evaluate various factors simultaneously with respect to GFR. p values < 0.05 (two-tailed) were considered significant.
RESULTS
The GA of the 147 preterm infants varied between 23.4 and 37 wk (mean 30.2 wk). The birth weight was between 560 and 3685 g (mean 1425 g). One hundred thirty (88%) of the children were appropriate for gestational age. One hundred seven (73%) were ventilated at d 3. GFR values at d 3 after birth ranged from 0.45 to 1.30 mL/min (mean 0.85 mL/min). GFR values increased significantly with GA (r = 0.60, p < 0.001). Multiple regression analysis showed the presence of a significant correlation between GFR and GA (p < 0.001). The percentage of explained variation of GFR considering only GA was 35.6%. Body weight did not exert a significant effect on the GFR (p = 0.21). Artificial ventilation (p = 0.50), RDS (p = 0.93), or small weight for GA (p = 0.33) also did not have a significant effect.
Timing before birth and cumulative dose of both indomethacin and betamethasone were analyzed. The median dose of indomethacin was 200 mg (range 100-2200 mg). The median dose of betamethasone was 24 mg (range 24120 mg). We could not detect an effect of the dose and timing before birth of both drugs given to the mother on the GFR values measured on d 3 of life.
The neonates were divided into four groups. Ninety-four infants were not prenatally exposed to betamethasone or indomethacin (group A). Twenty-six children were prenatally exposed to indomethacin alone (group B). Six children were prenatally exposed to betamethasone alone (group C). Twenty-one children were prenatally exposed to both betamethasone and indomethacin (group D). shows the clinical parameters including GA, birth weight, DISCUSSION and percentage of children who were appropriate for gestational age, ventilated, or had RDS. The GA of children
The data presented in this paper demonstrate the preswho were prenatally exposed to indomethacin with or ence of a GA-dependent increase of the GFR in preterm without betamethasone (groups B and D) was significantly infants. These findings are consistent with the results of lower compared with the GA of the infants who were not most previous reports (1-6). The increase of the GFR was prenatally exposed to betamethasone or indomethacin also associated with an increase in body weight. How-(group A). Table 2 delineates the relation between GA and ever, multivariate analysis showed that GA but not body GFR on d 3 of life after prenatal exposure to different weight was the major determinant for the development of combinations of betamethasone and indomethacin. After the GFR. Our results do not support the presence of a adjustment for the difference in GA between groups, the significant effect of clinical variables such as artificial GFR values of the patients in group B (only prenatal ventilation, RDS, and small size for gestational age on the exposure to indomethacin) were still significantly lower development of the GFR. This is in accordance with (-0.17 + 0.03 mL/min,p < 0.001) compared with the GFR some published studies (6, 14) . However, other studies values of the patients in group A (not exposed to indometh-showed a marked decrease in GFR in infants with RDS acin or betamethasone). No significant difference was pre- (15, 16) . Our patients were hemodynamically stable (disent between the GA-adjusted GFR values of the patients uresis > 1 mL/kg/h; systolic and diastolic blood pressure in group D (prenatal exposure to both betamethasone and above the third percentile adjusted for GA) and had no indomethacin) and group A (not exposed to indomethacin hypoxemia or hypercapnia. The lack of hypoxemia and or betamethasone). GA-adjusted GFR values of the pa-especially hypercarbia in our patients probably explains tients in group D (prenatal exposure to both betametha-our findings, indicating that RDS itself does not downsone and indomethacin) were significantly higher (+0.15 +-regulate GFR, but perhaps hypoxemia or hypercarbia 0.04 mL/min, p < 0.001) compared with the GA-adjusted does. GFR values of the infants in group B (prenatal exposure to In this study, most pregnant women who were treated indomethacin alone). A multivariate analysis was per-with betamethasone were also treated with indomethacin formed to analyze the impact of prenatal exposure to to inhibit preterm uterine contractions. The number of betamethasone and indomethacin on GFR values at d 3. patients exposed to betamethasone only was therefore Indomethacin use was associated with significantly lower too small for us to do a separate analysis. However, our (-0.15 t 0.03 mL/min, p < 0.001) GFR values, whereas analysis indicates that the GA-adjusted GFR of the chilbetamethasone use was associated with significantly higher dren who were prenatally exposed to both betametha-(+O.11 + 0.03 mL/min,p < 0.001) GFR values (Table 3 ). sone and indomethacin was significantly higher comAt d 10 after birth, GFR measurements were repeated pared with the GFR of the children who were prenatally in 40 children. During this 7-d period, a significant in-exposed to indomethacin alone. In addition, the GAcrease in GFR values (0.17 a 0.03 mLlmin,p < 0.001) to adjusted GFR values of the children who were prenatally normal levels was detected. This postnatal increase in exposed to both drugs were not different from the GFR GFR values was independent of GA and was not influ-values of the children who were not exposed at all (group enced by prenatal exposure to betamethasone or indo-A). The use of multivariate analysis allowed us to detect methacin.
an association between prenatal exposure to betamethasone and GFR values, showing significantly higher GFR values (+O.11 + 0.03 mL/min) at d 3 after birth after ther in an increase in renal blood flow or in direct vaso-dilation of the renal vasculature (17, 18) . Baylis and Brenner (19) provided evidence in a carefully delineated micropuncture study that values for single-nephron GFR were 25% higher in rats treated with methylprednisolone. Values for glomerular plasma flow rate were also 25% higher in the treatment group, whereas values of the transglomerular hydraulic pressure difference, afferent and efferent oncotic pressures, and filtration pressure equilibrium were similar between control animals and rats treated with methylprednisolone. These results indicated that the rise in single-nephron GFR was entirely due to an increase in glomerular plasma flow probably mediated by renal arteriolar vasodilation. The effects of prenatal exposure to betamethasone on the GFR of preterm infants have been studied by three groups (20) (21) (22) . These studies did not show an increase of the GFR during the first week of life after prenatal exposure to glucocorticoids. However, in these three studies, creatinine clearance was used as a less reliable marker for the GFR in preterm infants and a small number of children were studied. This might have prevented the authors from demonstrating an increase in the GFR in the first week of life after prenatal exposure to glucocorticoids. We hypothesize that prenatal exposure to betamethasone may lead to a direct vasodilating effect of the renal arterioles in preterm infants, which is probably mediated by glucocorticoid receptors.
Prenatal exposure to indomethacin resulted in significantly lower GFR values (-0.15 2 0.03 mL1min) at d 3 of life. This effect was independent of the cumulative dose of indomethacin given to the pregnant women, although 94% had received indomethacin within a period of 48 h before delivery. This effect of prenatal exposure to indomethacin on the development of the GFR at d 3 was independent of the GA and could no longer be detected at d 10 after birth. Animal studies have indicated that the inhibition of prostaglandin synthesis by indomethacin increases renal vascular resistance. This subsequently results in an impaired renal blood flow and a concomitant reduction in the GFR (23) . This holds also for short-term exposure in the human neonate. Some case reports show that prolonged prenatal use of indomethacin can lead to deleterious renal and extrarenal effects (8, 9, (24) (25) (26) , whereas other reports could not detect any serious side effects (10, 27) .
In summary, prenatal exposure to indomethacin significantly reduces GFR values at d 3 after birth. Betamethasone significantly increases GFR when coadministered prenatally with indomethacin. Our data suggest that betamethasone increases the GFR irrespective of the use of indomethacin. Some authors previously showed that prenatal exposure to indomethacin may lead to a decrease in GFR. However, we could not demonstrate a decrease in GFR when both drugs were given simultaneously. We suggest that an increase in renal plasma flow due to betamethasone may overcome intrarenal vasoconstriction secondary to the decreased synthesis of intrarenal prostaglandins by indomethacin. Additional studies are needed to delineate the proposed effects of both drugs.
